Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Mpox Biology, Outcome, Transmission and Epidemiology Project - HIV Immunization and Vaccination Against Mpox eXposure Trial

NCT06839989 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

NCT NCT06839989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06839989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Mpox Biology, Outcome, Transmission and Epidemiology Project - HIV Immunization and Vaccination Against Mpox eXposure Trial
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 4, 2025
Completion date
November 30, 2026
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mpox (monkeypox)